Abstract:Purpose: Suture placement and alkali burn to the cornea are often used to induce inflammatory corneal neovascularization (CorNV) models in animals. This study compares the changes in genome-wide gene expression under these two CorNV conditions in mice.Methods: CorNV were induced in Balb/c mice by three interrupted 10-0 sutures placed at sites about 1 mm from the corneal apex, or by alkali burns that were 2 mm in size in the central area of the cornea. At the points in time when neovascularization progressed most quickly, some eyeballs were subjected to histological staining to examine CorNV and inflammatory cells infiltration, and some corneas were harvested to extract mRNA for microarray assay. After normalization and filtering, the microarray data were subject to statistical analysis using Significance Analysis of Microarray software, and interested genes were annotated using the Database for Annotation, Visualization, and Integrated Discovery (DAVID) program. The expression change of classical proangiogenic molecule like vascular endothelial growth factor (VEGF) and antiangiogenic molecule like pigment epithelium-derived factor (PEDF) was further verified using western blotting.Results: Suture placement induced CorNV in the areas between the suture and limbus, but did not affect the transparency of the yet unvasuclarized areas of the corneas. In contrast, alkali burn caused edema and total loss of transparency of the whole cornea. Histology showed that sutures only caused localized epithelial loss and inflammatory infiltration between the suture and limbus, but chemical burn depleted the whole epithelial layer of the central cornea and caused heavy cellular infiltration of the whole cornea. At day 5 after suture placement, 1,055 differentially expressed probes were identified, out of which 586 probes were upregulated and 469 probes were downregulated. At a comparable time point, namely on day 6 after the alkali burn to the corneas, 472 probes were upregulated and 389 probes were downregulated. Among these differentially expressed probes, a significant portion (530 probes in total, including 286 upregulated and 244 downregulated probes) showed a similar pattern of change in both models. Annotation (using DAVID) of the overlapping differential genes revealed that the significant enrichment gene ontology terms were "chemotaxis" and "immune response" for the upregulated genes, and "oxidation reduction" and "programmed cell death" for the downregulated genes. Some genes or gene families (e.g., S100A family or alpha-, beta-, or gamma-crystallin family) that had not been related to corneal pathogenesis or neovascularization were also revealed to be involved in CorNV. VEGF was upregulated and PEDF was stable as shown with western blotting.Conclusions: Sutures and alkali burn to the corneas produced types of damage that affected transparency differentially, but gene profiling revealed similar patterns of changes in gene expression in these two CorNV models. Further studies of the primary genes found to be involved in CorNV will supplement current understanding about the pathogenesis of neovascularization diseases.

Multi-gene Targeted Antiangiogenic Therapies for Experimental Corneal Neovascularization

586. Development of Anti-Angiogenic Mirna Therapeutics for Corneal Neovascularization

739. rAAV Delivered MicroRNA Therapeutics Towards Efficacious Treatment of Corneal Neovascularization

A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization.

Combination of Vascular Endothelial Growth Factor Receptor/platelet-Derived Growth Factor Receptor Inhibition Markedly Improves the Antiangiogenic Efficacy for Advanced Stage Mouse Corneal Neovascularization

Gene-based therapeutic tools in the treatment of Cornea Disease.

Preventing and treating neurotrophic keratopathy by a single intrastromal injection of AAV-mediated gene therapy

Experimental study of inhibition of corneal neovascularization by adeno-associated virus mediated encoding endostatin gene transfection

Anti-apoptosis Effects of Vascular Endothelial Cadherin in Experimental Corneal Neovascularization.

Genome Editing VEGFA Prevents Corneal Neovascularization in Vivo

Transcriptome Profiling of Neovascularized Corneas Reveals Mir-204 As a Multi-target Biotherapy Deliverable by Raavs

A Synergistic Therapy with Antioxidant and Anti‐VEGF: Towards Its Safe and Effective Elimination for Corneal Neovascularization

Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA

Comparison of Genome-Wide Gene Expression in Suture- and Alkali Burn-Induced Murine Corneal Neovascularization

[Antisense Vascular Endothelial Growth Factor Suppressed Corneal Neovascularization in Rats].

Efficacy and safety of combined UV‐light corneal crosslinking and fine‐needle diathermy to regress pathological murine corneal (lymph)angiogenesis in vivo

Inhibited Experimental Corneal Neovascularization By Neutralizing Anti-Sdf-1 Alpha Antibody

A Synergistic Therapy with Antioxidant and Anti-VEGF: Toward Its Safe and Effective Elimination for Corneal Neovascularization

Experimental Inhibition of Corneal Neovascularization by Endostatin Gene Transfection in Vivo

Novel multi-targeted inhibitors suppress ocular neovascularization by regulating unique gene sets

Unlocking the therapeutic potential of the corneal endothelium: Intravital imaging reveals endogenous regenerative capabilities